The history of CD70 CAR began with the observation by Reither et al. that the CD70/CD27 axis promotes the stemness of AML blasts, and at the same time, they demonstrated that a hypomethylating agent (HMA) upregulated CD70 expression in LSCs [41]. This evidence concerns the gene CD27 and acute myeloid leukemia.